Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 2
2002 2
2003 4
2006 1
2007 2
2008 2
2010 1
2012 2
2013 1
2014 3
2015 1
2016 6
2017 6
2018 7
2019 8
2020 11
2021 10
2022 8
2023 4
2024 9
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial.
Collet JP, Van Belle E, Thiele H, Berti S, Lhermusier T, Manigold T, Neumann FJ, Gilard M, Attias D, Beygui F, Cequier A, Alfonso F, Aubry P, Baronnet F, Ederhy S, Kasty ME, Kerneis M, Barthelemy O, Lefèvre T, Leprince P, Redheuil A, Henry P, Portal JJ, Vicaut E, Montalescot G; ATLANTIS Investigators of the ACTION Group. Collet JP, et al. Among authors: manigold t. Eur Heart J. 2022 Aug 1;43(29):2783-2797. doi: 10.1093/eurheartj/ehac242. Eur Heart J. 2022. PMID: 35583186 Clinical Trial.
BRIGHT-4 trial: bivalirudin strikes back.
Piriou PG, Manigold T, Letocart V, Guérin P, Vourc'h M. Piriou PG, et al. Among authors: manigold t. Lancet. 2023 Apr 8;401(10383):1157-1158. doi: 10.1016/S0140-6736(23)00280-5. Lancet. 2023. PMID: 37030888 No abstract available.
Outcomes of transcatheter aortic valve implantation for native aortic valve regurgitation.
Le Ruz R, Leroux L, Lhermusier T, Cuisset T, Van Belle E, Dibie A, Palermo V, Champagnac D, Obadia JF, Teiger E, Ohlman P, Tchétché D, Le Breton H, Saint-Etienne C, Piriou PG, Plessis J, Beurtheret S, Du Chayla F, Leclère M, Lefèvre T, Collet JP, Eltchaninoff H, Gilard M, Iung B, Manigold T, Letocart V, Of Stop-As And France-Tavi Investigators OB. Le Ruz R, et al. Among authors: manigold t. EuroIntervention. 2024 Sep 2;20(17):e1076-e1085. doi: 10.4244/EIJ-D-24-00339. EuroIntervention. 2024. PMID: 39219361 Free PMC article.
Predictors of Outcomes of Reintervention After Transcatheter Aortic Valve Replacement: FRANCE 2 and FRANCE TAVI Registries.
Durand E, Eltchaninoff H, Tchetche D, Levesque T, Garmendia C, Iung B, Benamer H, Cayla G, Van Belle E, Commeau P, Le Breton H, Cuisset T, Akodad M, Verhoye JP, Beurtheret S, du Chayla F, Leclere M, Gilard M; STOP-AS and France TAVI Investigators; Dumonteil N. Durand E, et al. J Am Coll Cardiol. 2025 Mar 11;85(9):896-907. doi: 10.1016/j.jacc.2024.11.048. J Am Coll Cardiol. 2025. PMID: 40044295
Évolution de la prise en charge du rétrécissement aortique serré au centre hospitalier départemental de La Roche-sur-Yon, Vendée (2005, 2015 et 2022).
Perion M, Chan Peng J, Ropers L, Dimet J, Boiffard E, Baron O, Manigold T, Roussel JC, Guérin P, Pouliquen H. Perion M, et al. Among authors: manigold t. Ann Cardiol Angeiol (Paris). 2025 Sep 25;74(5):101954. doi: 10.1016/j.ancard.2025.101954. Online ahead of print. Ann Cardiol Angeiol (Paris). 2025. PMID: 41004876 French.
Letter by Le Ruz and Manigold Regarding Article, "Compared Outcomes ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER MI Trial".
Le Ruz R, Manigold T. Le Ruz R, et al. Among authors: manigold t. Circ Cardiovasc Interv. 2022 Jan;15(1):e011587. doi: 10.1161/CIRCINTERVENTIONS.121.011587. Epub 2022 Jan 18. Circ Cardiovasc Interv. 2022. PMID: 35041456 No abstract available.
Coronary Events After Transcatheter Aortic Valve Replacement: Insights From the France TAVI Registry.
Zendjebil S, Akodad M, Iung B, Dumonteil N, Cuisset T, le Breton H, Beurtheret S, du Chayla F, Leclère M, Sanguineti F, Hovasse T, Chevalier B, Neylon A, Eltchaninoff H, Garot P, Gilard M, Benamer H, Lefèvre T; STOP-AS and FRANCE-TAVI Investigators. Zendjebil S, et al. JACC Cardiovasc Interv. 2025 Jan 27;18(2):229-243. doi: 10.1016/j.jcin.2024.09.005. JACC Cardiovasc Interv. 2025. PMID: 39880575
Calcification of surgical aortic bioprostheses and its impact on clinical outcome.
Guimbretière G, Sénage T, Boureau AS, Roos JC, Bernard Q, Carlier B, Veziers J, Cueff C, Piriou N, Coste G, Fellah I, Lelarge C, Capoulade R, Jaafar P, Manigold T, Letocart V, Warin-Fresse K, Guérin P, Costa C, Vadori M, Galinañes M, Manez R, Soulillou JP, Cozzi E, Padler-Karavani V, Serfaty JM, Roussel JC, Le Tourneau T. Guimbretière G, et al. Among authors: manigold t. Eur Heart J Cardiovasc Imaging. 2024 Aug 26;25(9):1226-1234. doi: 10.1093/ehjci/jeae100. Eur Heart J Cardiovasc Imaging. 2024. PMID: 38606926
87 results